Hongjun Huang, Yong Jiang, Baoqiang Wu
*Department of Hepatobiliary Surgery, The First People's Hospital of Changzhou, Soochow University, Changzhou, Jiangsu †Department of Hepatobiliary Surgery, The Shaoxing Hospital of China Medical University, Shaoxing, Zhejiang, China.
Surg Laparosc Endosc Percutan Tech. 2015 Jun;25(3):218-22. doi: 10.1097/SLE.0000000000000133.
To compare the difference of primary suture following 3-port laparoscopic common bile duct exploration (LCBDE) between modified transcystic and transcholedochal approach in the treatment of choledocholithiasis.
Patients who underwent 3-port LCBDE by modified transcystic approach (n = 80) and those who underwent 3-port LCBDE by transcholedochal approach (n = 209) were included in this study. The operative time, duration of hospital stay, diameter of the cystic duct, diameter of the common bile duct (CBD), complications, and demographics were retrospectively analyzed in all patients.
All operations were successfully performed. No patient was converted to laparotomy. No mortality was associated with the 2 groups. There was no significant difference between the 2 groups for the operative time (91.94 ± 34.21 min vs. 96.13 ± 32.15 min), duration of hospital stay (9.82 ± 3.48 d vs. 10.74 ± 5.34 d), diameter of cystic duct (0.47 ± 0.09 cm vs. 0.47 ± 0.08 cm), and complications (2.5% vs. 2.87%) (all P > 0.05). A significant difference was observed in terms of the diameter of CBD (1.18 ± 0.29 cm vs. 1.04 ± 0.24 cm P < 0.05).
The modified transcystic LCBDE was safe and feasible for treating choledocholithiasis but it might be more suitable for the CBD with a smaller diameter.
比较改良经胆囊管与经胆总管途径的三孔腹腔镜胆总管探查术(LCBDE)在治疗胆总管结石时一期缝合的差异。
本研究纳入了采用改良经胆囊管途径行三孔LCBDE的患者(n = 80)和采用经胆总管途径行三孔LCBDE的患者(n = 209)。对所有患者的手术时间、住院时间、胆囊管直径、胆总管(CBD)直径、并发症及人口统计学资料进行回顾性分析。
所有手术均成功完成。无患者中转开腹。两组均无死亡病例。两组在手术时间(91.94 ± 34.21分钟 vs. 96.13 ± 32.15分钟)、住院时间(9.82 ± 3.48天 vs. 10.74 ± 5.34天)、胆囊管直径(0.47 ± 0.09厘米 vs. 0.47 ± 0.08厘米)及并发症(2.5% vs. 2.87%)方面均无显著差异(均P > 0.05)。在胆总管直径方面观察到显著差异(1.18 ± 0.29厘米 vs. 1.04 ± 0.24厘米,P < 0.05)。
改良经胆囊管LCBDE治疗胆总管结石安全可行,但可能更适用于直径较小的胆总管。